Publications
5539 Results
- Journal / Conference
- Blood 102(11):(#135)
- Year
- 2003
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-9321
Comparable survival in multiple myeloma (MM) with high dose therapy (HDT) employing MEL 140 mg/m2 + TBI 12 Gy autotransplants versus standrad dose therapy with VBMCP and no benefit from interferon (IFN) maintenance: results of Intergroup trial S9321
- Journal / Conference
- Blood 102(11):(#1417)
- Year
- 2003
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8819
Loss of MHC class II gene and protein expression in diffuse large B cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival: a follow-up study to the NIH director's challenge leukemia and lymphoma molecular profiling project (LLMPP)
- Journal / Conference
- Blood 102(11):(#3321)
- Year
- 2003
- Research Committee(s)
- Lymphoma
Loss of major histocompatibility class II (MHCII) expression in nodal diffuse large B cell lymphoma (DLBCL) is highly coordinated and unlikely related to chromosomal deletions
- Journal / Conference
- Blood 102(11):(#621)
- Year
- 2003
- Research Committee(s)
- Lymphoma
Gene expression microarray analysis of de novo CD5+ diffuse large B-cell lymphoma (LLMPP study): a distinct entity?
- Journal / Conference
- Journal of Clinical Oncology 21(23s):246s-252s
- Year
- 2003
Estimating the impact of new clinical trial proven cancer therapy and cancer chemoprevention on population mortality: the Karnofsky memorial lecture
- Journal / Conference
- Controlled Clinical Trials 24(3S)Suppl:50S (#14)
- Year
- 2003
- Research Committee(s)
- Prevention and Epidemiology
- Study Number(s)
- S0000
Effectiveness of a media based launch to recruit to a prostate cancer prevention trial
- Journal / Conference
- Proc of the American Society of Clinical Oncology 22:710(#2856)
- Year
- 2003
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-9035
HLA D3(7) confers a poor prognosis in intermediate thickness (1.5-4.0mm) melanoma: serotyping of 553 patients on SWOG 9035.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 22:566(#2278)
- Year
- 2003
- Research Committee(s)
- Myeloma
- Study Number(s)
- S9628
High dose dexamethasone (Dex) with maintenance Dex/alpha interferon lead to improved survival in patients with primary systemic amyloidosis: results of US Intergroup Trial Southwest Oncology Group (SWOG) S9628.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 22:634(#2548)
- Year
- 2003
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9416
Induction chemoradiotherapy and surgical resection for non-small cell lung carcinomas of the superior sulcus (pancoast tumors): mature results of Southwest Oncology Group trial 9416 (Intergroup trial 0160)
- Journal / Conference
- Controlled Clinical Trials 24(3S):47S(#10)
- Year
- 2003
- Research Committee(s)
- Prevention and Epidemiology
- Study Number(s)
- S0000